Clearance for First Phase 2 Clinical Trial for Eye Diseases
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Mesoblast
- Response to ASXPrice Query
- Price Query
- Positive Results in Phase 2 Lumbar Spinal Fusion Trial
- MSB Provides Corporate Strategy For Neurologic Product
- Mesoblast Corporate Overview - CEO Message to AGM
Later from Mesoblast
All Mesoblast news releasesFollow Mesoblast into a list and get an email when it puts out news.
Follow Mesoblast